KORU Medical Systems (NASDAQ:KRMD – Get Free Report) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it weigh in compared to its peers? We will compare KORU Medical Systems to related companies based on the strength of its analyst recommendations, profitability, risk, dividends, valuation, earnings and institutional ownership.
Profitability
This table compares KORU Medical Systems and its peers’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| KORU Medical Systems | -4.03% | -10.63% | -6.51% |
| KORU Medical Systems Competitors | -278.16% | -150.10% | -21.89% |
Institutional and Insider Ownership
58.6% of KORU Medical Systems shares are held by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are held by institutional investors. 18.5% of KORU Medical Systems shares are held by company insiders. Comparatively, 14.8% of shares of all “Healthcare Equipment & Supplies” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Earnings & Valuation
This table compares KORU Medical Systems and its peers gross revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| KORU Medical Systems | $41.13 million | -$2.64 million | -81.75 |
| KORU Medical Systems Competitors | $1.89 billion | $138.79 million | 11.29 |
KORU Medical Systems’ peers have higher revenue and earnings than KORU Medical Systems. KORU Medical Systems is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
Risk and Volatility
KORU Medical Systems has a beta of 0.47, indicating that its share price is 53% less volatile than the S&P 500. Comparatively, KORU Medical Systems’ peers have a beta of 2.57, indicating that their average share price is 157% more volatile than the S&P 500.
Analyst Ratings
This is a summary of recent ratings for KORU Medical Systems and its peers, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| KORU Medical Systems | 1 | 1 | 4 | 0 | 2.50 |
| KORU Medical Systems Competitors | 4266 | 10507 | 18257 | 826 | 2.46 |
KORU Medical Systems currently has a consensus price target of $7.00, suggesting a potential upside of 114.07%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 16.37%. Given KORU Medical Systems’ stronger consensus rating and higher possible upside, equities analysts clearly believe KORU Medical Systems is more favorable than its peers.
Summary
KORU Medical Systems beats its peers on 8 of the 12 factors compared.
KORU Medical Systems Company Profile
KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.
Receive News & Ratings for KORU Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KORU Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.
